{"id":"W4413316564","doi":"10.1182/bloodadvances.2024015282","title":"Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Takeda Oncology; Genentech; National Institutes of Health; Kyowa Hakko Kirin; Memorial Sloan-Kettering Cancer Center; Chugai Pharmaceutical; Celltrion; Seagen; Kite Pharma; Gilead Sciences; Eisai; BeiGene; Daiichi Sankyo Europe; Sanofi; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"CHOP; Medicine; Prednisone; Internal medicine; Vincristine; Anaplastic large-cell lymphoma; Cyclophosphamide; Lymphoma; Oncology; Peripheral T-cell lymphoma; Chemotherapy; Gastroenterology; Immunology; T cell; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001594782,0.0001246397,0.000477765,0.0002442994,0.00002273611,0.000009788639,0.0001841266,0.00008284899,0.00009317133],"category_scores_gemma":[0.0006787968,0.00008074744,0.00008973454,0.0006609123,0.00006261886,0.00008861344,0.0000273927,0.0001645931,0.000001037864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001509751,"about_ca_system_score_gemma":0.0003436815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001369482,"about_ca_topic_score_gemma":0.0006622518,"domain_scores_codex":[0.9981914,0.0004280653,0.0004054427,0.0001983953,0.0005439734,0.0002327302],"domain_scores_gemma":[0.9982365,0.001168181,0.0001742375,0.0002946437,0.0001014971,0.000024975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1837915,0.002180246,0.75769,0.0001833694,0.0001441947,0.00003938712,0.001888565,0.00002995237,0.04746595,0.00003552786,0.00006906072,0.006482257],"study_design_scores_gemma":[0.1459961,0.002384686,0.7862008,0.0002275029,0.0001167067,0.000004576729,0.001879947,0.00002811351,0.05454617,0.0001262934,0.008356874,0.0001322329],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928603,0.000826154,0.00000392441,0.002228135,0.00008220494,0.0008225738,0.000006929178,0.00001037282,0.003159408],"genre_scores_gemma":[0.9902163,0.0003027412,0.0002492481,0.0001599967,0.00003943397,0.00007051973,0.000003363359,0.00001128312,0.008947178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03779534,"threshold_uncertainty_score":0.3292785,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01115092441455895,"score_gpt":0.3162519335843498,"score_spread":0.3051010091697908,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}